Clinical trials
Active, not recruiting Prostatic Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aragon Pharmaceuticals, Inc. | 4 |
| Novartis Pharmaceuticals | 4 |
| AstraZeneca | 2 |
| Bayer | 2 |
| Eli Lilly and Company | 2 |
| Janssen Research & Development, LLC | 2 |
| Martini-Klinik am UKE GmbH | 2 |
| Pfizer | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 39 |
| Neoplasm Metastasis | 3 |
| Neoplasms | 3 |
| Prostatic Neoplasms, Castration-Resistant | 2 |
| Breast Neoplasms | 1 |
| Bulbo-Spinal Atrophy, X-Linked | 1 |
| Disease | 1 |
| Recurrence | 1 |
| Urogenital Neoplasms | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.